Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The Chinese-German Journal of Clinical Oncology
Metadata
Title
Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer
Authors
Bin Wang
Ning Wang
Chunyan Xue
Bin Jiang
Yajie Wang
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
The Chinese-German Journal of Clinical Oncology / Issue 6/2008
Print ISSN: 1610-1979
Electronic ISSN: 1613-9089
DOI
https://doi.org/10.1007/s10330-008-0030-2

Other articles of this Issue 6/2008

The Chinese-German Journal of Clinical Oncology 6/2008 Go to the issue

OriginalPaper

Clinical utility of proton magnetic resonance spectroscopy in the diagnosis of breast tumors

OriginalPaper

Clinical observation of gemcitabine and concomitant three-dimensional conformal radiotherapy in the treatment of locally advanced non-small cell lung cancer

OriginalPaper

Non-viral targeted delivery system mediates transfection of thymidine kinase gene of herpes simplex virus into ovarian cancer cells: a comparison between one time and continuous mediation

OriginalPaper

Protection of a cytidine deaminase gene gainst toxicity of high dose chemotherapy in mice

OriginalPaper

Application of mastoscopic in modified radical operation for preserving nipple-areolar complex

OriginalPaper

CT image fusion in the evaluation of radiation treatment planning for non-small cell lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits